Effect of fiduxosin, an antagonist selective for α1A- and α1D-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs

Journal of Pharmacology and Experimental Therapeutics

Volumn 300, Issue 2, 2002, Pages 487-494

  Brune, Michael E ^a   Katwala, Sweta P ^a   Milicic, Ivan ^a   Witte, David G ^a   Kerwin Jr , James F ^a   Meyer, Michael D ^a   Hancock, Arthur A ^a   Williams, Michael ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; FIDUXOSIN; TAMSULOSIN; TERAZOSIN; UNCLASSIFIED DRUG;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BINDING AFFINITY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; HYPOTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; URETHRA PRESSURE; URINARY TRACT FUNCTION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HETEROCYCLIC COMPOUNDS, 3-RING; MALE; PHENYLEPHRINE; PRAZOSIN; PROSTATE; PYRIMIDINONES; RECEPTORS, ADRENERGIC, ALPHA-1; REGIONAL BLOOD FLOW; SULFONAMIDES; URETHRA;

EID: 0036158054     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.300.2.487     Document Type: Article

References (40)

1. 1-adrenoceptor antagonists prazosin, tamsulosin and Ro 70-004
2. 1A-adrenoceptor antagonist, in men with benign prostatic hyperplasia (BPH)
3. Pharmacological antagonism of α-adrenergic agonist induced increases in canine intraurethral pressure in vivo
4. 1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs
5. IV. International Union of Pharmacology nomenclature of adrenoceptors
6. Introduction and concluding remarks
7. 1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction
8. α-adrenoceptor subclassification in vascular smooth muscle
9. RS-17053 (N-[2-(2-cyclopropylme thoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H -indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: Implications for adrenoceptor classification
10. 1C subtype
11. High prevalence of benign prostatic hypertrophy in the community
12. Natural history of prostatism: Impact of urinary symptoms on quality of life in 2115 randomly selected community men
13. Natural history of prostatism: Relationship among symptoms, prostate volume and peak urinary flow rate
14. 1 adrenergic receptor (AB) subtype gene expression during bladder outlet obstruction of rats
15. 1-adrenoceptor subtypes: A synopsis of their pharmacology and molecular pharmacology
16. Actions of A-131701, a novel, selective antagonist for α1A- compared to α1B-adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity
17. Pharmacological characterization of A-131701, a novel, α1-adrenoceptor antagonist selective for α1A- and α1D-compared to α1B-adrenoceptors
18. 1A/D receptor antagonist with enhanced in vivo uroselectivity relative to terazosin and tamsulosin
19. 1-adrenoceptor antagonist with uroselective properties
20. Prostatic disorders in the dog
21. The natural history of benign prostatic hyperplasia: What have we learned in the last decade?
22. 1A subtype
23. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): Role of the alpha-1L adrenoceptor in tissue selectivity
24. Binding and functional properties of alpha-1 adrenoceptors and the area density of smooth muscle in the canine prostate
25. The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle
26. A comparison of the binding and functional properties of alpha-1 adrenoceptors and area density of smooth muscle in the human, canine and rat prostates
27. Alpha 1-adrenergic receptor subtypes in human detrusor
28. Alpha-blockers and lower urinary tract function: More than smooth muscle relaxation?
29. 1-adrenoceptors
30. Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle
31. Differential vascular alpha 1-adrenoceptor antagonism by tamsulosin and terazosin
32. Alpha1-adrenergic receptors in human spinal cord: Specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels
33. Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics
34. 1A-adrenoceptor agonist, selectively increases urethral pressure in dogs
35. Identification of alpha 1-adrenoceptor subtypes in the human prostatic urethra
36. The sympathetic nervous system in essential hypertension
37. 1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel α1A-adrenoceptor selective antagonists
38. Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin
39. Modeling of the relationships between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure and mean arterial pressure in conscious dogs treated with terazosin, doxazosin, tamsulin and fiduxosin
40. 1-adrenoceptor subtypes